Adenocarcinoma, Basal Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
123
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Adenocarcinoma, Oxyphilic
|
disease |
Neoplasms
|
Neoplastic Process
|
135
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Carcinoma, Cribriform
|
disease |
Neoplasms
|
Neoplastic Process
|
117
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Carcinoma, Granular Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
116
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Adenocarcinoma, Tubular
|
disease |
Neoplasms
|
Neoplastic Process
|
133
|
3
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Heart Failure, Right-Sided
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
154
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Giant Cell Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
95
|
3
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Malignant mesothelioma
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
420
|
12
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Nicotine Use Disorder
|
phenotype |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
14
|
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Down Syndrome, Partial Trisomy 21
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
19
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Trisomy 21, Meiotic Nondisjunction
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
19
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Chronic Alcoholic Hepatitis
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
5
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Trisomy 21, Mitotic Nondisjunction
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
19
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Cardiotoxicity
|
disease |
Pathological Conditions, Signs and Symptoms; Chemically-Induced Disorders; Cardiovascular Diseases; Wounds and Injuries
|
Injury or Poisoning
|
13
|
1
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Staphylococcus aureus infection
|
disease |
Infections
|
Disease or Syndrome
|
49
|
4
|
0.300 |
None |
1.000 |
1 |
|
2013 |
2013 |
Hepatic Form of Wilson Disease
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Digestive System Diseases; Nutritional and Metabolic Diseases; Nervous System Diseases
|
Disease or Syndrome
|
24
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Myocardial Failure
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
119
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Heart Decompensation
|
phenotype |
Cardiovascular Diseases
|
Pathologic Function
|
113
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Serum total cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
486
|
1243
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Acanthamoeba Keratitis
|
disease |
Infections; Eye Diseases
|
Disease or Syndrome
|
22
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Acanthosis Nigricans
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
64
|
11
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Acquired Immunodeficiency Syndrome
|
group |
Infections; Immune System Diseases
|
Disease or Syndrome
|
243
|
42
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Acute bronchiolitis
|
disease |
Infections; Respiratory Tract Diseases
|
Disease or Syndrome
|
11
|
3
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Adnexal Diseases
|
group |
Female Urogenital Diseases and Pregnancy Complications
|
Disease or Syndrome
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Adrenal gland hypofunction
|
phenotype |
Endocrine System Diseases
|
Disease or Syndrome
|
90
|
10
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |